Bumper Offer - Urjas oil Just @ Rs. 1
Telekast L Tablet (15) is a commercial drug that is prescribed in the form of Tablet. Other than this, Telekast L Tablet (15) has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Telekast L Tablet (15) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Telekast L Tablet (15) include Headache, Stomach ache, Joint pain. These side effects of Telekast L Tablet (15) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Telekast L Tablet (15) is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Telekast L Tablet (15) related warnings talks about Telekast L Tablet (15)'s effects on the liver, heart and kidney.
Telekast L Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions.
Drug interactions for Telekast L Tablet (15) have been reported in the medical literature. See below for a complete list.
You should also be aware that Telekast L Tablet (15) is not safe while driving, and is not addiction.
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Telekast L Tablet (15) safe for pregnant women?
Pregnant women may get severe side effects after taking Telekast L. If you are pregnant, do not take Telekast L without a doctor's advice.
Is the use of Telekast L Tablet (15) safe during breastfeeding?
Telekast L may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Telekast L Tablet (15) on the Kidneys?
In the absence of any research, there are no known side effects of Telekast L on kidneys.
What is the effect of Telekast L Tablet (15) on the Liver?
There is no research available on the side effects of Telekast L on the liver. Therefore, its impact is unknown.
What is the effect of Telekast L Tablet (15) on the Heart?
No research work has been carried out till date on effects of Telekast L on heart. So it is not known whether taking Telekast L will cause side effects on heart or not.
Telekast L Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Telekast L Tablet (15) unless your doctor advises you to do so -
Is this Telekast L Tablet (15) habit forming or addictive?
Telekast L Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Telekast L Tablet (15), you should not drive or work on any heavy machine, as Telekast L Tablet (15) can make you drowsy.
Is it safe?
Telekast L Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Telekast L Tablet (15) for mental disorders.
Interaction between Food and Telekast L Tablet (15)
Due to a lack of research, nothing can be said about the consequences of taking Telekast L Tablet (15) together with food.
Interaction between Alcohol and Telekast L Tablet (15)
Due to lack of research, there is no information about the side effects of taking Telekast L Tablet (15) with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Product Index [Internet]: MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ). Ciplamed
Highlights of Prescribing Information [Internet]: XYZAL® (levocetirizine dihydrochloride) tablets . Initial U.S. Approval: 19952007
Smpc [Internet]: montelukast sodium. Aurobindo Pharma
Package leaflet Information for the patient [Internet]: Xyzal 0.5 mg/ml oral solution. UCB Pharma Ltd
